Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

2(40.0%)

5Total

N/A(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03943745Completed

EEG Changes During Induction of Propofol Anesthesia

Role: collaborator

NCT05655260Not ApplicableRecruiting

PErsonalized TReatment for Endometrial Carcinoma

Role: collaborator

NCT05084937Not ApplicableEnrolling By Invitation

Celiac Disease in Childhood-Adulthood Transition

Role: collaborator

NCT04634448Not ApplicableNot Yet Recruiting

The Prevalence of Appendiceal Tumours in Periappendicular Abscess

Role: collaborator

NCT03434951Phase 4Unknown

Intrathecal Morphine and Local Infiltration Analgesia in Total Knee Arthroplasty

Role: lead

NCT00908089Phase 4Unknown

TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis

Role: collaborator

NCT01136993Unknown

Finnish Telestroke Pilot 2007-2009

Role: collaborator

NCT00812747Completed

Surgical Wound Infections After Vascular Surgery: Prospective Multicenter Trial

Role: collaborator

All 8 trials loaded